23 August 2021
Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.
12 August 2021
On the 12th of August, the Duchenne Research Relay Team cycled to the MDUK Oxford Neuromusuclar Centre for a passing of the baton from the Centre's researchers to the relay team to fundraise for Duchenne Muscular Dystrophy.
14 July 2021
After almost 50 years at Oxford, Professor Dame Kay Davies is soon to retire – well…. mostly… Kay talks to Sarah Whitebloom about her early years at Somerville fresh out of state school, how she balanced motherhood with the demands of her burgeoning career, and her long held passion to find a cure for Duchenne muscular dystrophy. Thank you Kay for your long years of service and dedication. You are truly an inspiration to many!
27 June 2021
On the 27th of June, the MDUK Oxford Neuromusuclar Centre Town and Gown Team once again embarked on the beautiful 10km course around Oxford city centre in MDUK’s first socially distanced run.
6 May 2021
Early diagnosis is of primary importance both to obtain the best effect of innovative medications and to accelerate their development, writes Professor Laurent Servais.
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
15 October 2020
The Harrington Discovery Institute (HDI) in the US has announced five winners of its inaugural UK Rare Disease Scholar Award competition, including a key investigator of the MDUK Oxford Neuromusuclar Centre, Professor Angela Russell.
13 May 2020
The Academy of Medical Sciences, the independent body in the UK representing the diversity of medical science, has announced the election of fifty new Fellows, including two academics from the MDUK Oxford Neuromuscular Centre.
19 February 2020
The Centre hosted a very successful first annual scientific meeting on 12 February 2020 at St Anne’s College, Oxford, including all research groups in the Centre as well as a panel of international experts in the field.
11 November 2019
The launch of the MDUK Oxford Neuromuscular Centre marks an exciting new stage in the partnership between Muscular Dystrophy UK and the University of Oxford, with the goal of delivering new experimental medicines and developing enhanced clinical trial capacity in adult and paediatric neuromuscular diseases.
18 September 2019
Collaborative research between teams from the Department of Paediatrics and the Institut de Myologie shows how antisense oligonucleotides can penetrate muscles to treat myotonic dystrophy type 1, a rare muscle disease.
22 May 2019
Spinraza – the first treatment for the rare condition spinal muscular atrophy (SMA) – is set to be available for NHS use for children and adults with SMA Types 1, 2 and 3.
1 April 2019
MDUK Oxford Neuromuscular Centre Researchers Raise Funds for their runners in the MDUK Oxford Town and Gown
25 March 2019
Acclaimed clinical researcher, Professor Laurent Servais, has been appointed Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre.